Carina Dolan, PharmD, BCOP, discusses the factors that impact the successful uptake of biosimilars in the practice of oncology.
Carina Dolan, PharmD, BCOP
Advertisement
Articles by Carina Dolan, PharmD, BCOP
Advertisement
Latest Updated Articles
Biosimilar Uptake in Oncology Faces Many HurdlesJuly 17th 2018
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to BI-1808 Plus Pembrolizumab in Ovarian Cancer
2
FDA Grants Accelerated Approval to RP1 Plus Nivolumab for Advanced Melanoma After Anti–PD-1 Therapy
3
FDA Flashback: Breast Cancer Decisions and News From July 2026
4
Dostarlimab Monotherapy Elicits Responses in First-Line PD-L1-Positive HNSCC
5